1/56
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Placental abruption
Most common obstetric cause of antepartum hemorrhage
• Tone – uterine atony
• Tissue – retained placental tissue or blood clots
• Trauma – genital tract lacerations or hematomas
• Thrombin - coagulopathy
The "4 T's" of postpartum hemorrhage
Placenta previa
Abnormal implantation of placenta over internal cervical os
Complete previa
Placenta completely covers internal os
Partial previa
Placenta covers portion of internal os
Marginal previa
Edge of placenta reaches margin of os
Low-lying placenta
Implantation in lower uterine segment in proximity but not extending to internal os
Painless vaginal bleeding, with a sentinel bleed at >28 weeks AOG
Most typical sign of placenta previa
Placenta migration
Apparent movement of the placenta away from the internal os
Morbidly adherent placenta
Abnormal adherence of part or all of the placenta to the uterine wall
Nitabuch layer
The layer where the trophoblasts meet the decidua basalis
Placenta accreta
Villi are attached to the myometrium
Placenta increta
Villi actually invade the myometrium
Placenta percreta
Villi that penetrate through the myometrium and to or through the serosa
Total accreta
Abnormal adherence may involve all lobules
Partial accreta
Involves few to several cotyledons
Focal accreta
A single lobule is abnormally attached
Placenta previa, or prior CS delivery
Most significant risk factors in morbidy adherent placenta
Swiss cheese appearance of the myometrium
Ultrasound sign that refers to placental vascular lacunae or "lakes" which represent dilated vessels extending from the placenta through the myometrium
CS hysterectomy regardless of AOG
Management for morbidly adherent placenta with significant bleeding
CS hysterectomy at 34 to 35 6/7 weeks AOG, after giving corticosteroids
Management for morbidly adherent placenta that is asymptomatic
• After 1 CS: 3%
• After 2 CS: 11%
• After 3 CS: 40%
• After 4 CS: 61%
• After 5 CS: 67%
Rates of concurrent placenta accrete in patients who had prior CS deliveries
Vasa previa
· Occurs when a velamentous cord insertion causes the fetal vessels to pass over the internal os
· Also seen with velamentous and succenturiate placentas
Velamentous placenta
Occurs when blood vessels insert between the amnion and the chorion, away from the margin of the placenta, leaving the vessels largely unprotected and vulnerable to compression or injury
Succenturiate placenta
· An extra lobe of the placenta is implanted at some distance away from the rest of the placenta
· Fetal vessels may course between the two lobes, possibly over the cervix, leaving these blood vessels unprotected and at risk for rupture
Placental abruption (abruptio placentae)
Premature separation of implanted placenta from uterine wall, resulting in hemorrhage
Concealed hemorrhage
Bleeding confined in uterine cavity (20% of abruptions)
Revealed or external hemorrhage
Blood dissects toward cervix (80% abruptions)
History of previous abruption
Strongest risk factor for abruption (8- to 12-fold risk increase)
• 5.8 - 22% after one abruptio
• >50% after two abruptio
Risk of abruption in future pregnancy
Third trimester vaginal bleeding (78%)
Most common history finding in abruptio placenta
Couvelaire uterus
A term for a bluish purple myometrium as seen on surface of uterus in abruptio placenta
• 0.5-0.1% in prior low-transverse CS delivery
• 6-12% in prior classical CS delivery
Rates of uterine rupture for previous low-transverse and classical CS delivery
Nonreassuring fetal HR pattern
Most common sign of uterine rupture
Apt test
Laboratory test for determining the presence of fetal RBCs in maternal blood
34-36 weeks AOG
If patient is diagnosed with vasa previa, patients may opt for elective CS at what AOG?
• Cumulative blood loss > 1000 mL OR
• blood loss + signs and symptoms of hypovolemia
Blood volume loss required for a diagnosis of postpartum hemorrhage
Vaginal wall hematoma
Location of hematoma to be ruled out if patient has large drop in Hct after delivery without no visible bleeding site
Retroperitoneal hematoma
Location of hematoma to be ruled out if patient has large drop in Hct with low back pain
Uterine atony
Leading cause of postpartum hemorrhage
• IV oxytocin (20U in 1L crystalloid x 10 mL/min) OR
• IM oxytocin (10U)
Typically given prophylactically after delivery to prevent uterine atony
Methylergonovine
Second-line drug given for uterine atony
• Carboprost or Prostaglandin F2α
• Dinoprostone, a Prostaglandin E2 analog
• Misoprostol, a Prostaglandin E1 analog
Third-line drugs given for uterine atony
• Bimanual uterine compression
• Balloon tamponade (Bakri)
• Surgical procedures – uterine compression sutures (e.g., B-Lynch sutures), pelvic vessel ligation, embolization, or hysterectomy
Management options for bleeding unresponsive to uterotonic agents
Uterine inversion
Complete or partial turning-out of the uterus
Manual replacement
First step in management of uterine inversion
Laparotomy
Second-line management if unsuccessful manual replacement of inverted uterus
Huntington procedure
Laparotomy technique in resolving uterine inversion that uses atraumatic clamps used to apply upward traction to round ligaments
Haultain incision
Laparotomy technique in resolving uterine inversion that utilizes a sagittal cut to release constriction ring
Amniotic fluid embolism
Occurs due to embolization of meconium-laden amniotic fluid→AF and debris obstruct pulmonary artery flow
Abruptio placenta
Most common cause of disseminated intravascular coagulation
• Hypofibrinogenemia (<150 mg/dL)
• Thrombocytopenia
• Prolonged PT/PTT
Laboratory findings in DIC
Recombinant factor VIIa
Clotting factor that may be beneficial in severe cases of DIC
<25 volume percent
Rapid blood infusion should be done when hematocrit reaches...?
<50,000/uL
Platelet concentrate infusion should be given if platelet count is less than...?
Fresh frozen plasma in doses of 10-15 mL/kg or cryoprecipitate
Adjuncive therapy in a patient with prolonged PT/PTT with surgical bleeding
3-4%
Percent increase in Hct per unit of transfused compatible whole blood